BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33365297)

  • 1. Quantitative SARS-CoV-2 Antibody Screening of Healthcare Workers in the Southern Part of Kyoto City During the COVID-19 Pre-pandemic Period.
    Fujita K; Kada S; Kanai O; Hata H; Odagaki T; Satoh-Asahara N; Tagami T; Yasoda A
    Front Public Health; 2020; 8():595348. PubMed ID: 33365297
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA.
    Thomas SN; Altawallbeh G; Zaun CP; Pape KA; Peters JM; Titcombe PJ; Dileepan T; Rapp MJ; Bold TD; Schacker TW; Arbefeville S; Ferrieri P; Thyagarajan B; Jenkins MK; Karger AB
    Clin Biochem; 2021 Apr; 90():15-22. PubMed ID: 33539808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
    Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
    BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
    Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
    Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
    Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
    PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.
    Nishida T; Iwahashi H; Yamauchi K; Kinoshita N; Okauchi Y; Suzuki N; Inada M; Abe K
    Medicine (Baltimore); 2021 Jun; 100(25):e26433. PubMed ID: 34160433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.
    Korth J; Wilde B; Dolff S; Anastasiou OE; Krawczyk A; Jahn M; Cordes S; Ross B; Esser S; Lindemann M; Kribben A; Dittmer U; Witzke O; Herrmann A
    J Clin Virol; 2020 Jul; 128():104437. PubMed ID: 32434708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study.
    Iversen K; Bundgaard H; Hasselbalch RB; Kristensen JH; Nielsen PB; Pries-Heje M; Knudsen AD; Christensen CE; Fogh K; Norsk JB; Andersen O; Fischer TK; Jensen CAJ; Larsen M; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Hother CE; Gybel-Brask M; Sørensen E; Harritshøj L; Folke F; Sten C; Benfield T; Nielsen SD; Ullum H
    Lancet Infect Dis; 2020 Dec; 20(12):1401-1408. PubMed ID: 32758438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study.
    Hildebrandt A; Hökelekli O; Uflacker L; Rudolf H; Gatermann SG
    Int J Hyg Environ Health; 2021 Jun; 235():113771. PubMed ID: 34049092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
    Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
    J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Seroprevalence of SARS-CoV-2 (COVID-19)-Specific Antibodies among Healthcare Workers: A Cross-Sectional Study in Guilan, Iran.
    Balou HA; Yaghubi Kalurazi T; Joukar F; Hassanipour S; Shenagari M; Khoshsorour M; Mansour-Ghanaei F
    J Environ Public Health; 2021; 2021():9081491. PubMed ID: 34691195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests.
    van Dam P; Huizing M; Roelant E; Hotterbeekx A; De Winter FHR; Kumar-Singh S; Moons P; Amajoud Z; Vulsteke C; Croes L; Janssens A; Berneman Z; Prenen H; Meuris L; Vanden Berghe W; Smits E; Peeters M
    Eur J Cancer; 2021 May; 148():328-339. PubMed ID: 33773276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea.
    Kim YK; Minn D; Song DY; Lee CH; Ryoo NH; Jeon CH; Song KE; Suh JS; Chang SH
    J Korean Med Sci; 2021 Nov; 36(43):e294. PubMed ID: 34751011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.